An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Drug Acquiring Traction Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts directly for source information, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Some professionals said the popularity for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the service has taken down problematic material and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for preparing or injecting at residence.
After moments of entering one group, a vendor shared contact information, where most transactions occur. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Item Information and Costs
Within these groups, posts display black plastic packages with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to potentially serious medical dangers”.
